University of Chicago SC - 2 — Chicago, Illinois

University of Chicago SC - 2 is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Chicago SC - 2 has participated in 1 clinical trials.

Therapeutic areas: Tuberous Sclerosis Complex-associated Refractory Seizures.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago SC - 2?

University of Chicago SC - 2 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago SC - 2 conducted?

University of Chicago SC - 2 has 1 clinical trials on record. Their work covers Tuberous Sclerosis Complex-associated Refractory Seizures.

Is University of Chicago SC - 2 accredited by Crixeo Health?

University of Chicago SC - 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago SC - 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.